Last reviewed · How we verify
NCT04406181
Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic
NA trial testing HADS in Anxiety and Fear in 200 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Universitair Ziekenhuis Brussel |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 200 |
| Start date | 18 May 2020 |
| Primary completion | 31 December 2020 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- HADS
- a survey
Conditions studied
- Anxiety and Fear — all drugs for Anxiety and Fear →
- Anxiety Depression — all drugs for Anxiety Depression →
- Anxiety Postoperative — all drugs for Anxiety Postoperative →
- Psychological Stress — all drugs for Psychological Stress →
Sponsor
Universitair Ziekenhuis Brussel — full company profile →
Who can join
Adults 18 to 90, any sex, with Anxiety and Fear or Anxiety Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The effect and impact of postponing cardiac surgery / creating a waiting list as a result of COVID-19 on patients, both psychologically and symptomatically on three groups of patients: 1. The degree of anxiety and/or depression induced by their altered medical care trajectory. 2. The incidence of medical problems induced by deferred elective surgery or delayed postoperative ambulatory visit 3. The occurrence of reduced access to medical and psychological help
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04406181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HADS
Trials testing the same drug.
- NCT04573400 — Prevalence of Neuropsychiatric Manifestations in IBD Patients in Upper Egypt · unknown
- NCT04106011 — Cognitive Changes With Gabapentin Treatment · terminated
- NCT03856086 — Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients · NA · completed
Other recruiting trials for Anxiety and Fear
Currently open trials in the same condition.
- NCT06531980 — Effectiveness of a Digital Application for Adolescents With Mild to Moderate Anxiety · NA · recruiting
- NCT06697275 — Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children · NA · recruiting
- NCT06917300 — Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergoing Spine Surgery · NA · recruiting
- NCT06004115 — Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression · Phase 4 · recruiting
- NCT03821779 — Prefrontal Oscillations in Social Anxiety Disorder (POSAD) · NA · active not recruiting
Other Universitair Ziekenhuis Brussel trials
Trials by the same sponsor.
- NCT07536230 — Deep Learning Framework for Continuous Depth of Anesthesia Forecasting · not yet recruiting
- NCT07533968 — The Aim of This Study is to Gain Insight Into the Occurrence of Irritable Bowel Symptoms During Ovarian Stimulation in I · NA · not yet recruiting
- NCT07289984 — Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders and · NA · not yet recruiting
- NCT06923813 — Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calo · NA · recruiting
- NCT07401004 — Effect of Blink-Based Training on Cancer Detection in Colorectal Polyp Images by Medical Students/Non GI-trainees · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04406181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitair Ziekenhuis Brussel
- Last refreshed: 1 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04406181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing